 NEWARK, N.J., June 14, 2021 PRNewswire -- Rafael Holdings, Inc., NYSE: RFL, a pharmaceutical company focused on developing novel cancer metabolism therapeutics, today announced the appointment of three senior biopharmaceutical leaders to its Board of Directors: Ameet Mallik, Chief Executive Officer of Rafael Holdings; Shannon Thyme Klinger, Chief Legal Officer of Moderna, Inc., NASDAQ GS: MRNA; and Mark McCamish, M.D. 